# Ondergewicht verhoogt complicatierisico na TAVI aanzienlijk — DOUBLE CHOICE

*geplaatst 2026-11-20 · Algemeen · Clinical research in cardiology : official journal of the German Cardiac Society · doi 10.1007/s00392-026-03042-x · https://hartvaat.nl/2026/11/12/ondergewicht-verhoogt-complicatierisico-na-tavi-aanzienlijk-double-choice/*

In een subgroep-analyse van de gerandomiseerde DOUBLE CHOICE trial onderzochten onderzoekers de voorspellende waarde van BMI op 30-dagen uitkomsten na TAVI bij 752 patiënten. Obese patiënten (BMI ≥30 kg/m²²) hadden een lager risico op de primaire eindpunten (mortaliteit, vaat- en bloeding-complicaties, infecties en neurologische events) met een gecorrigeerde OR van 0,48, terwijl ondergewicht (BMI <20 kg/m²²) onafhankelijk geassocieerd was met een verdrievoudigd risico (OR 3,74). Deze bevindingen bevestigen het obesiteitsparadox-fenomeen en markeren ondergewicht als een kwetsbaar profiel dat extra aandacht vereist bij preoperatieve risicostratificatie en zorgplanning.

## English: Underweight and obesity as outcome predictors after transcatheter aortic valve implantation: insights from the DOUBLE-CHOICE trial.

A prespecified subgroup analysis of the randomized DOUBLE CHOICE trial evaluated BMI as a predictor of 30-day outcomes following transcatheter aortic valve implantation (TAVI) in 752 patients. After multivariable adjustment, obesity (BMI ≥30 kg/m²²) was independently associated with a lower risk of the primary composite endpoint (adjusted OR 0.48), whereas underweight status (BMI <20 kg/m²²) significantly increased procedural risk (adjusted OR 3.74). These findings reinforce the obesity paradox in TAVI and highlight underweight as a high-risk phenotype warranting closer pre-procedural assessment and tailored perioperative care.

## Abstract (original, from the publication)

BACKGROUND: An "obesity paradox" has been described after transcatheter aortic valve implantation (TAVI), suggesting lower mortality in patients with higher body mass index (BMI) despite greater comorbidity. In contrast, underweight consistently predicts adverse outcomes. Whether these associations reflect a true biological effect or are primarily driven by residual confounding, frailty, and patient selection remains uncertain. METHODS: This prespecified subgroup analysis included eligible patients from the randomized DOUBLE-CHOICE trial comparing two transcatheter heart valves and two anesthesia strategies (minimalist approach with local anesthesia only vs. standard care with conscious sedation). The primary endpoint was a 30-day composite of all-cause mortality, vascular and bleeding complications, infections requiring antibiotic therapy, and neurologic events. Associations were evaluated using multivariable logistic regression adjusted for age, sex, frailty, diabetes, hypertension, chronic kidney disease, and anesthesia strategy. RESULTS: Among 752 patients (BMI ≥ 30 kg/m2, n = 192; BMI < 30 kg/m2, n = 560), obese patients had lower rates of the 30-day primary endpoint (15.2% vs. 27.6%; p < 0.001). After multivariable adjustment, obesity remained independently associated with lower risk (adjusted OR 0.48, 95% CI 0.30-0.75; p = 0.002). In contrast, underweight (BMI < 20 kg/m2; n = 23) was associated with a higher incidence of the primary endpoint (55.0% vs. 23.4%; p = 0.003) and remained an independent predictor after adjustment (adjusted OR 3.74, 95% CI 1.30-9.52; p = 0.005). CONCLUSION: In this randomized TAVI population, obesity was independently associated with favorable 30-day outcomes, whereas underweight identified a small but high-risk subgroup with substantially increased procedural risk. These findings identify underweight as a potential high-risk phenotype requiring further investigation in future studies incorporating more detailed measures of frailty and body composition.

Auteurs: Maria Buske, Mohamed Abdel-Wahab, Joerg Ender, Steffen Desch, Niklas Lankisch, Helene Schrader, Sebastian von der Emde, Philipp Lauten, Tanja K Rudolph, Tobias Geisler, Steffen Massberg, Matti Adam, Stephan Baldus, Samuel Sossalla, Michael Joner, Helge Möllmann, Alexander Wolf, Won-Keun Kim, Michael A Borger, Thilo Noack, Andreas Boening, Sabine Bleiziffer, Sven Hohenstein, Holger Thiele, Hans-Josef Feistritzer

---
Bron: Clinical research in cardiology : official journal of the German Cardiac Society, https://doi.org/10.1007/s00392-026-03042-x. Bijgewerkt 2026-11-13T02:44:31Z. Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies.
